Campbell & Co Investment Adviser’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $249K | Buy |
+2,318
| New | +$249K | 0.02% | 1009 |
|
|
2024
Q1 | – | Sell |
-8,777
| Closed | -$507K | – | 1119 |
|
|
2023
Q4 | $507K | Buy |
+8,777
| New | +$507K | 0.05% | 702 |
|
|
2023
Q3 | – | Sell |
-17,145
| Closed | -$927K | – | 957 |
|
|
2023
Q2 | $927K | Buy |
17,145
+6,682
| +64% | +$361K | 0.17% | 177 |
|
|
2023
Q1 | $523K | Buy |
10,463
+5,366
| +105% | +$268K | 0.1% | 403 |
|
|
2022
Q4 | $236K | Buy |
+5,097
| New | +$236K | 0.06% | 635 |
|
|
2022
Q2 | – | Sell |
-11,050
| Closed | -$489K | – | 691 |
|
|
2022
Q1 | $489K | Buy |
+11,050
| New | +$489K | 0.13% | 286 |
|
|
2019
Q2 | – | Sell |
-12,958
| Closed | -$497K | – | 539 |
|
|
2019
Q1 | $497K | Buy |
+12,958
| New | +$497K | 0.24% | 120 |
|
|
2018
Q2 | – | Sell |
-10,080
| Closed | -$275K | – | 385 |
|
|
2018
Q1 | $275K | Buy |
+10,080
| New | +$275K | 0.23% | 195 |
|
|
2016
Q4 | – | Sell |
-15,217
| Closed | -$362K | – | 146 |
|
|
2016
Q3 | $362K | Buy |
+15,217
| New | +$362K | 0.97% | 31 |
|
|
2014
Q3 | – | Sell |
-210,381
| Closed | -$2.69M | – | 196 |
|
|
2014
Q2 | $2.69M | Buy |
+210,381
| New | +$2.69M | 1.07% | 34 |
|
|
2014
Q1 | – | Sell |
-108,968
| Closed | -$1.31M | – | 215 |
|
|
2013
Q4 | $1.31M | Buy |
+108,968
| New | +$1.31M | 0.29% | 108 |
|